Taiwan FDA registration 0333e73d093873b85d594d34d9b33c94
"Siemens" Aspartine transaminase assay reagent
TW: “西門子” 天門冬胺酸轉胺酶檢驗試劑
Taiwan·Risk Class 2·RANDOX LABORATORIES LTD.;; Siemens Healthcare Diagnostics Inc.·Registered Jan 15, 2019 – Jan 15, 2029ActiveRegistration details
- Analysis ID
- 0333e73d093873b85d594d34d9b33c94
- Customs Code
- DHA05603211307
Company information
- Manufacturer Country
- United Kingdom;;United States
- Authorized Representative
- SIEMENS HEALTHCARE LIMITED
Product details
- Intended Use
- This product is used in vitro for in vitro diagnosis and needs to be used with Atellica CH Analyzer to quantitatively detect aspartine transaminasase activity in human serum and plasma (lithium heparin).
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1100 天門冬胺酸轉胺酶試驗系統
- Import Information
- Contract manufacturing;; input
Dates and status
- Registration Date
- Jan 15, 2019
- Expiry Date
- Jan 15, 2029
About this record
Access comprehensive regulatory information for "Siemens" Aspartine transaminase assay reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 0333e73d093873b85d594d34d9b33c94 and manufactured by RANDOX LABORATORIES LTD.;; Siemens Healthcare Diagnostics Inc.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices